- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT03527563
Study on Internet Medical Models for the Management of Patients With Hypertension in China
A Comparative Study on Internet Medical Models and Conventional Medical Models for the Management of Patients With Hypertension in China
Přehled studie
Detailní popis
Protocol Title:A Comparative Study on Internet Medical Models and Conventional Medical Models for the Management of Patients with Hypertension in China Study Indication:Hypertension Number of Site:16sites Study Duration (from the initiation of the first site to the end of the follow-up for the last subject): 12 months Duration of Treatment and Management: 6 months Planned Number of Subjects:958 subjects, 479 in each group(blood pressure management in Internet medical model, Conventional medical model) Internet Medical Model:Using Internet blood pressure management model: home blood pressure self-monitoring + Internet diagnosis + Maintained or adjusted anti-hypertension drug(s) treatment.
Conventional Medical Model:Using Conventional blood pressure management model: home blood pressure monitoring + face-to-face diagnosis in clinic + Maintained or adjusted anti-hypertension drug(s) treatment.
Inclusion Criteria:
- Male or female, 45 to 75 years old (including 45and 75 years);
- Two measurements of resting systolic blood pressure ≥ 140mmHg and/or diastolic blood pressure ≥ 90mmHg on different days during screening;
Female subjects of child-bearing potential who are willing to adopt one of the following methods for contraception during the study:
- Oral contraceptive, either combined or progestogen alone.
- Injectable progestogen.
- Implants of levonorgestrel.
- Oestrogenic vaginal ring.
- Percutaneous contraceptive patches.
- Intrauterine device or intrauterine system showing that the expected failure rate is less than 1% per year as stated in the product label.
- Double barrier method: condom and an occlusive cap (diaphragm or cervical/vault caps) with a vaginal spermicidal agent (foam/gel/film/cream/suppository).
- Subjects who can understand and perform home blood pressure monitoring as required by the study;
- Subjects who voluntarily participate in the study and sign informed consent form.
Exclusion Criteria:
- Two measurements of resting systolic blood pressure ≥ 180mmHg and/or diastolic blood pressure ≥ 110mmHg on different days during screening;
- Subjects with the history of cerebral stroke within 6 months prior to screening;
- Subjects with the history of myocardial infarction within 6 months prior to screening;
- Subjects with the history of heart failure;
- Subjects with the history of atrial fibrillation;
- Subjects with the history of coronary artery revascularization;
- Subjects with other serious diseases, such as tumor;
- Subjects diagnosed as the secondary hypertension;
- Subjects with congenital or acquired organic heart disease;
- Pregnant or lactant subjects;
- Subjects with severe mental disease;
- Subjects with abnormal liver and renal function: ALT or AST>2 X upper limit value; Or creatinine > 2X upper limit value
- Subjects who were previously diagnosed with diabetes that is currently poorly controlled: FBG>10mmol/L;
- Subjects who are unable to conduct blood pressure self-test;
- The subject has any other known condition at screening that would compromise subject safety, might affect life expectancy, or making it difficult to successfully manage and follow the subject according to the protocol.
Efficacy Evaluations:
Primary Efficacy Endpoints:
- Blood pressure control rate of subjects in the two groups at Month 6 Secondary Efficacy Endpoints:
- Blood pressure control rate of subjects in the two groups at Month 3
- Blood pressure value of subjects in the two groups at Month 3 and Month 6
- Change of blood pressure of subjects in the two groups at Month 3 and Month 6
- Variability of blood pressure of subjects in the two groups at Month 3 and Month 6
- Treatment compliance of subjects in the two groups at Month 3 and Month 6
- Medical expense of subjects in the two groups at Month 3 and Month 6
- Treatment satisfaction of subjects in the two groups at Month 3 and Month 6
Typ studie
Zápis (Očekávaný)
Fáze
- Nelze použít
Kontakty a umístění
Studijní kontakt
- Jméno: jie jiang, doctor
- Telefonní číslo: 13601155975
- E-mail: jiangjie417@vip.163.com
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Popis
Inclusion Criteria:
- Male or female, 45 to 75 years old (including 45 and 75 years);
- Two measurements of resting systolic blood pressure ≥140mmHg and/or diastolic blood pressure ≥90mmHg on different days during screening;
Female subjects of child-bearing potential who are willing to adopt one of the following methods for contraception during the study:
Oral contraceptive, either combined or progestogen alone. Injectable progestogen. Implants of levonorgestrel. Oestrogenic vaginal ring. Percutaneous contraceptive patches. Intrauterine device or intrauterine system showing that the expected failure rate is less than 1% per year as stated in the product label.
Double barrier method: condom and an occlusive cap (diaphragm or cervical/vault caps) with a vaginal spermicidal agent (foam/gel/film/cream/suppository).
- Subjects who can understand and perform home blood pressure monitoring as required by the study;
- Subjects who voluntarily participate in the study and sign informed consent form.
Exclusion Criteria:
- Two measurements of resting systolic blood pressure ≥180mmHg and/or diastolic blood pressure ≥110mmHg on different days during screening;
- Subjects with the history of cerebral stroke within 6 months prior to screening;
- Subjects with the history of myocardial infarction within 6 months prior to screening;
- Subjects with the history of heart failure;
- Subjects with the history of atrial fibrillation;
- Subjects with the history of coronary artery revascularization;
- Subjects with other serious diseases, such as tumor;
- Subjects diagnosed as the secondary hypertension;
- Subjects with congenital or acquired organic heart disease;
- Pregnant or lactant subjects;
- Subjects with severe mental disease;
- Subjects with abnormal liver and renal function: ALT or AST>2 X upper limit value; Or creatinine >2 X upper limit value;
- Subjects who were previously diagnosed with diabetes that is currently poorly controlled: FBG>10mmol/L;
- Subjects who are unable to conduct blood pressure self-test;
- The subject has any other known condition at screening that would compromise subject safety, might affect life expectancy, or making it difficult to successfully manage and follow the subject according to the protocol.
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Jiný
- Přidělení: Randomizované
- Intervenční model: Paralelní přiřazení
- Maskování: Žádné (otevřený štítek)
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
---|---|
Jiný: Internet Medical Model
Using Internet blood pressure management model: home blood pressure self-monitoring + Internet diagnosis + Maintained or adjusted anti-hypertension drug(s) treatment.
|
Subjects in the Internet group should upload blood pressure monitoring data at least once per day.
It is highly recommended to upload two pressure monitoring results to capture more blood pressure information.
The warning value of blood pressure set in the cloud database is systolic blood pressure ≥ 180mmHg or ≤ 100mmHg and diastolic blood pressure ≥ 110mmHg or ≤ 60mmHg.
After enrollment, subjects and physicians communicate via telephone or Internet every two weeks until blood pressure is well controlled judged by physician.
Then the frequency of communication will be changed to once a month.
Once there are lacks of blood pressure data in 3 days of each week, or. blood pressure values of the subject exceed the warning value in 2 days of consecutive 3 days, the physician will take the initiative to contact the patient for disease inquiry.
|
Žádný zásah: Conventional Medical Model
Using Conventional blood pressure management model: home blood pressure monitoring + face-to-face diagnosis in clinic + Maintained or adjusted anti-hypertension drug(s) treatment.
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
---|---|---|
Primary endpoint: blood pressure control rate of subjects in the two groups at Month 6
Časové okno: 6 months
|
Definition of blood pressure control rate is that the percent of subjects with systolic blood pressure <140 mm Hg and diastolic blood pressure < 90 mm Hg
|
6 months
|
Spolupracovníci a vyšetřovatelé
Sponzor
Spolupracovníci
Publikace a užitečné odkazy
Obecné publikace
- Pickering TG, Miller NH, Ogedegbe G, Krakoff LR, Artinian NT, Goff D; American Heart Association; American Society of Hypertension; Preventive Cardiovascular Nurses Association. Call to action on use and reimbursement for home blood pressure monitoring: a joint scientific statement from the American Heart Association, American Society of Hypertension, and Preventive Cardiovascular Nurses Association. J Cardiovasc Nurs. 2008 Jul-Aug;23(4):299-323. doi: 10.1097/01.JCN.0000317429.98844.04.
- Lawes CM, Vander Hoorn S, Rodgers A; International Society of Hypertension. Global burden of blood-pressure-related disease, 2001. Lancet. 2008 May 3;371(9623):1513-8. doi: 10.1016/S0140-6736(08)60655-8.
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia (Očekávaný)
Primární dokončení (Očekávaný)
Dokončení studie (Očekávaný)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Aktuální)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Klíčová slova
Další relevantní podmínky MeSH
Plán pro data jednotlivých účastníků (IPD)
Plánujete sdílet data jednotlivých účastníků (IPD)?
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Studuje produkt zařízení regulovaný americkým úřadem FDA
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .
Klinické studie na Internet Medical Model
-
Soterix MedicalNYU Langone HealthDokončeno
-
Soterix MedicalGeorgetown University; National Institute of Neurological Disorders and Stroke... a další spolupracovníciDokončenoChronická afázieSpojené státy
-
Baylor College of MedicineAktivní, ne náborDefekty neurální trubiceSpojené státy
-
Abbott Medical DevicesDokončeno
-
Cordio MedicalDokončenoSrdeční selháníIzrael
-
Baylor College of MedicineMaterna MedicalDokončenoPilotní studie k vyhodnocení předběžné bezpečnosti a proveditelnosti zdravotnického zařízení MaternaSlza, pánevní orgán, porodnické traumaSpojené státy
-
Abbott Medical DevicesUkončeno
-
University of WashingtonDokončeno
-
Altura Medical Inc.NeznámýAneuryzmata břišní aortyChile, Lotyšsko
-
University of South FloridaNábor